Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study

Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, Louisiana 70121, USA.

OBJECTIVES: This study was performed to assess the influence and interdependence of immunologic and nonimmunologic risk factors in the development of cardiac allograft vasculopathy. Another primary objective was to establish a clinically useful model for risk assessment of cardiac allograft vasculopathy that would facilitate identifying those heart transplant recipients likely to have severe intimal proliferation and thereby at greater risk for adverse clinical events. BACKGROUND: To our knowledge, no comprehensive intravascular ultrasound study has assessed the relative influences of both nonimmunologic and immunologic factors in the development of cardiac allograft vasculopathy, currently the major limitation to long-term cardiac allograft survival. METHODS: Using a computer-assisted model of stepwise logistic regression, immunologic and nonimmunologic risk factors were evaluated to help identify the development of severe intimal thickening in 101 subjects who underwent intravascular ultrasound. Prospective validation of the findings was performed in a separate consecutive cohort of 37 heart transplant recipients, and the accuracy of this model to predict a relative risk > 1 for the development of severe intimal hyperplasia was assessed. RESULTS: Significant independent predictors of severe intimal hyperplasia in this model included a donor age > 35 years, a first-year mean biopsy score > 1 (a measure not only of severity of rejection, but also of frequency of insidious rejection) and hypertriglyceridemia at two incremental levels of risk (150 to 250 mg/dl [1.70 to 2.83 mmol/liter] and > 250 mg/dl [2.83 mmol/liter]). Based on the absence (0) or presence (1) of these factors, 12 individual categories of risk were ascertained with increasing relative risks and predicted probabilities for severe intimal hyperplasia. Prospective validation of this model revealed a sensitivity and specificity of 70% and 90%, respectively, and the positive and negative predictive values were 85% and 80%, respectively. Additionally, subjects with severe intimal thickening had a four-fold higher cardiac event rate than those without severe intimal proliferation on intravascular ultrasound. CONCLUSIONS: This study establishes a clinically useful predictive model that can be applied to individual heart transplant recipients to assess their risk for developing significant cardiac allograft vasculopathy and, thus, aids in the identification of patients at risk for cardiac events in whom closer surveillance and risk factor modification may be warranted.

This article has been cited by other articles:

				M. Rahmani, R. P. Cruz, D. J. Granville, and B. M. McManus Allograft Vasculopathy Versus Atherosclerosis Circ. Res., October 13, 2006; 99(8): 801 - 815. [Abstract] [Full Text] [PDF]

				E. M. Tuzcu, S. R. Kapadia, R. Sachar, K. M. Ziada, T. D. Crowe, J. Feng, W. A. Magyar, R. E. Hobbs, R. C. Starling, J. B. Young, et al. Intravascular Ultrasound Evidence of Angiographically Silent Progression in Coronary Atherosclerosis Predicts Long-Term Morbidity and Mortality After Cardiac Transplantation J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1538 - 1542. [Abstract] [Full Text] [PDF]

				R. L. Benza, G. J. Zoghbi, J. Tallaj, R. Brown, J. K. Kirklin, M. Hubbard, B. Rayburn, B. Foley, D. C. McGiffin, L. J. Pinderski, et al. Palliation of allograft vasculopathy with transluminal angioplasty: A decade of experience J. Am. Coll. Cardiol., June 2, 2004; 43(11): 1973 - 1981. [Abstract] [Full Text] [PDF]

				M. R. Mehra, P. A. Uber, H. O. Ventura, R. L. Scott, and M. H. Park The impact of mode of donor brain death on cardiac allograft vasculopathy: An intravascular ultrasound study J. Am. Coll. Cardiol., March 3, 2004; 43(5): 806 - 810. [Abstract] [Full Text] [PDF]

				H. O. Ventura and M. R. Mehra C-Reactive protein and cardiac allograft vasculopathy: is inflammation the critical link? J. Am. Coll. Cardiol., August 6, 2003; 42(3): 483 - 485. [Full Text] [PDF]

				J. C. Fang, S. Kinlay, D. Behrendt, H. Hikita, J. L. Witztum, A. P. Selwyn, and P. Ganz Circulating Autoantibodies to Oxidized LDL Correlate With Impaired Coronary Endothelial Function After Cardiac Transplantation Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2044 - 2048. [Abstract] [Full Text] [PDF]

				M. R. Mehra, P. A. Uber, K. Vivekananthan, S. Solis, R. L. Scott, M. H. Park, R. V. Milani, and C. J. Lavie Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1609 - 1614. [Abstract] [Full Text] [PDF]

				S. M. Hollenberg, L. W. Klein, J. E. Parrillo, M. Scherer, D. Burns, P. Tamburro, M. Oberoi, M. R. Johnson, and M. R. Costanzo Coronary Endothelial Dysfunction After Heart Transplantation Predicts Allograft Vasculopathy and Cardiac Death Circulation, December 18, 2001; 104(25): 3091 - 3096. [Abstract] [Full Text] [PDF]

				V. Marti, I. Romeo, R. Aymat, J. Garcia, P. Guiteras, M. Ballester, N. Aminian, J. M. Caralps, and J. M. Auge Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1174 - 1180. [Abstract] [Full Text] [PDF]

				S. R. Kapadia, S. E. Nissen, K. M. Ziada, G. Rincon, T. D. Crowe, N. Boparai, J. B. Young, and E. M. Tuzcu Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study J. Am. Coll. Cardiol., July 1, 2001; 38(1): 206 - 213. [Abstract] [Full Text] [PDF]

				H. Valantine, P. Rickenbacker, M. Kemna, S. Hunt, Y.-D. I. Chen, G. Reaven, and E. B. Stinson Metabolic Abnormalities Characteristic of Dysmetabolic Syndrome Predict the Development of Transplant Coronary Artery Disease : A Prospective Study Circulation, May 1, 2001; 103(17): 2144 - 2152. [Abstract] [Full Text] [PDF]

				P. J. Hauptman, K. J. O'Connor, R. E. Wolf, and B. J. McNeil Angiography of potential cardiac donors J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1252 - 1258. [Abstract] [Full Text] [PDF]

				K Pethig, V Klauss, B Heublein, H Mudra, A Westphal, C Weber, K Theisen, and A Haverich Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors Heart, November 1, 2000; 84(5): 494 - 498. [Abstract] [Full Text]

				C. A. Labarrere, D. R. Nelson, S. J. Miller, J. M. Nieto, J. A. Conner, D. E. Pitts, P. C. Kirlin, and H. G. Halbrook Value of Serum-Soluble Intercellular Adhesion Molecule-1 for the Noninvasive Risk Assessment of Transplant Coronary Artery Disease, Posttransplant Ischemic Events, and Cardiac Graft Failure Circulation, September 26, 2000; 102(13): 1549 - 1555. [Abstract] [Full Text] [PDF]

				T. Aziz, P. Hasleton, A. W. Hann, N. Yonan, A. Deiraniya, and I. V. Hutchinson TRANSFORMING GROWTH FACTOR {beta} IN RELATION TO CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 700 - 708. [Abstract] [Full Text] [PDF]

				P.F. Ludman, F. Lazem, M. Barbir, and M. Yacoub Incidence and clinical relevance of coronary calcification detected by electron beam computed tomography in heart transplant recipients Eur. Heart J., February 2, 1999; 20(4): 303 - 308. [Abstract] [PDF]